Stay updated on Dose Determination and Efficacy of Vesleteplirsen Clinical Trial
Sign up to get notified when there's something new on the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page.

Latest updates to the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded comprehensive Locations sections listing sites in California, Connecticut, Florida, Georgia, Iowa, Kansas, Massachusetts, Pennsylvania, Texas, Washington, Ontario, and Lancashire, with an update to revision v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision updated from v3.3.1 to v3.3.2, which appears to be an administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed, a minor administrative update that does not affect study details; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedThe notice about government funding and NIH operating status has been removed from the page. Other trial details such as title, design, eligibility criteria, locations, and primary/secondary outcomes remain unchanged.SummaryDifference0.3%

- Check67 days agoChange DetectedNo significant changes detected on the Study Details page for NCT04004065. The content and layout appear unchanged.SummaryDifference0.4%

- Check95 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference4%

Stay in the know with updates to Dose Determination and Efficacy of Vesleteplirsen Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page.